Goldberg, Joshua
Currais, Antonio
Ates, Gamze http://orcid.org/0000-0002-9323-3465
Huang, Ling
Shokhirev, Maxim
Maher, Pamela http://orcid.org/0000-0003-0694-0610
Schubert, David
Funding for this research was provided by:
Bruce Ford and Anne Smith Bundy Foundation
Shiley Foundation
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG054714)
The Paul F. Glenn Center for Aging at Salk
Article History
Received: 6 May 2020
Accepted: 6 August 2020
First Online: 24 August 2020
Competing interests
: D.S. is an unpaid advisor for Abrexa Pharmaceuticals, a company working on the development of J147 for AD therapy. The Salk Institute holds the patents for J147. The remaining authors declare no competing interests.